Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Merck Sharp & Dohme LLC | 832 |
| 2 | F Hoffmann La Roche AG | 810 |
| 3 | Bristol Myers Squibb Co | 511 |
| 4 | BASF SE | 352 |
| 5 | Novartis AG | 345 |
| 6 | Bayer AG | 313 |
| 7 | Janssen Pharmaceutica NV | 223 |
| 8 | Organon Pharma UK Ltd | 199 |
| 9 | AstraZeneca AB | 191 |
| 10 | FMC Corp | 185 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07D | Heterocyclic compounds | 20,630 |
| 2 | A61P | Therapeutic activity (drug indications) | 17,081 |
| 3 | A61K | Medicinal preparations | 11,676 |
| 4 | C07C | Acyclic and carbocyclic compounds | 3,507 |
| 5 | A01N | Preservation of bodies; biocides; pest repellents | 3,064 |
| 6 | C07F | Organometallic compounds | 1,882 |
| 7 | C07B | General methods of organic chemistry | 1,249 |
| 8 | C07K | Peptides | 953 |
| 9 | Y02P | Climate change mitigation: production | 704 |
| 10 | H10K | Organic semiconductors / OLEDs | 666 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Matthias Beller | University of Rostock | 2 |
| 2 | Richard A. J. O’Hair | The University of Melbourne | 2 |
| 3 | Ryan Patrick McLaughlin | Seattle University | 2 |
| 4 | Satoshi Sakaguchi | Kansai University | 2 |
| 5 | Victor Ryzhov | Northern Illinois University | 2 |
| 6 | Yasutaka Ishii | Kansai University | 2 |
| 7 | A. Rosowsky | Harvard University | 1 |
| 8 | Adam D. Moorhouse | University of London | 1 |
| 9 | Adrian K. Y. Lam | The University of Melbourne | 1 |
| 10 | Alan C. Sartorelli | Yale University | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Efficient Conversion of Aromatic Amines into Azides: A One-Pot Synthesis of Triazole Linkages | 2007 | 404 | Chemical Synthesis and Analysis |
| Chemoselective Nitration of Phenols with tert-Butyl Nitrite in Solution and on Solid Support | 2009 | 124 | Chemical Synthesis and Analysis |
| Convenient and mild synthesis of nitroarenes by metal-free nitration of arylboronic acids | 2011 | 109 | Catalytic Cross-Coupling Reactions |
| Iron-Promoted C–C Bond Cleavage of 1,3-Diketones: A Route to 1,2-Diketones under Mild Reaction Conditions | 2011 | 97 | Catalytic C–H Functionalization Methods |
| First iron-catalyzed synthesis of oximes from styrenes | 2009 | 90 | Catalytic C–H Functionalization Methods |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of tert-butyl nitrite?
Which pharmaceutical companies have the most patents involving this compound?
What are the primary research areas involving tert-butyl nitrite based on published papers?
What technology classifications dominate the patent landscape for this compound?
How has patent activity for this compound trended in recent years?